Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Registrational Phase III Studies of APG-2449 Cleared by China CDE for the Treatment of Patients with NSCLC 2024-10-08 10:26
CNOOC Limited Brings On-stream Bozhong 19-2 Oilfield Development Project 2024-10-08 08:00
Innovent and Ask Pharm Announce Strategic Collaboration for Limertinib, a Third-generation EGFR TKI for the Treatment of Lung Cancer 2024-10-08 08:00
Australian TGA Approves Additional Indication for Telix's Illuccix® to Include Patient Selection for PSMA-Targeted Therapy 2024-10-08 04:00
Vantiva and Harmonic Partner to Offer Service Providers Easy Transition from DOCSIS to Fiber-based PON Technologies 2024-10-08 02:25
SUNON Unveils Innovative Liquid Cooling Solutions for High-Performance Applications at the 2024 OCP Global Summit in San Jose 2024-10-07 23:00
Prenetics Announces Second Quarter 2024 Financial Results 2024-10-07 20:30
IFS strengthens Executive Board with CIO and CHRO appointments 2024-10-07 18:44
Sinch Honored with Frost & Sullivan's Enlightened Growth Leadership Award 2024-10-07 15:45
Adyen appoints Ben Wong as General Manager, Southeast Asia and Hong Kong 2024-10-07 14:30
Antengene to Present Results from Three Programs at the 2024 SITC Annual Meeting 2024-10-07 13:14
HKBN Appoints Dr Denis Yip as President and Group Chief Operating Officer 2024-10-07 11:11
SquareX Presents Industry-First Browser Detection Response Solution at GovWare 2024 -- A Must-See for Cybersecurity Leaders 2024-10-07 08:25
Arcadium Lithium Confirms Approach by Rio Tinto 2024-10-07 05:32
Cyient DLM Expands Global Footprint with Strategic Acquisition of US-Based EMS Manufacturer 2024-10-04 21:00
Hyundai and Waymo Enter Multi-Year, Strategic Partnership 2024-10-04 18:00
Vieworks to Showcase VT Sense Series at VISION 2024 2024-10-04 16:00
Clarivate in partnership with Abiquifi Announces Annual Summit LATAM Agenda 2024-10-04 15:00
Sirnaomics Has Been Subscribed for 17,527,696 Subscription Shares, New Capital Injection to Promote Business Growth and Development 2024-10-04 13:03
ABL Bio Announces Clinical Collaboration to Evaluate ABL103 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors 2024-10-04 12:40
1 24 25 26 27 28 1172